Menstrual Cramps Treatment Market Growth Accelerated by Increasing prevalence of Dysmenorrhea

 

Menstrual cramps treatment products are used for providing relief from symptoms caused due to menstrual cramps or dysmenorrhea. These products help relieve pain and discomfort associated with cramps which usually occur in the lower abdomen and lower back. Increasing prevalence of dysmenorrhea among womenis driving the demand for menstrual cramp treatment products. The global Menstrual Cramps Treatment Market is estimated to be valued at US$ 652.03 Mn in 2023 and is expected to exhibit a CAGR of 4.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The increasing prevalence of dysmenorrhea is a major trend fueling the growth of the menstrual cramps treatment market. Dysmenorrhea refers to painful menstrual cramps and according to research approximately 60-93% of women experience menstrual crampsat some point. Changes in lifestyle and lack of physical activity have led to increase in the incidence of menstrual cramps among women. For instance, according to a survey conducted by the Japanese Obstetric and Gynecologic Association in 2018, nearly 70% women in Japan suffered from dysmenorrhea. This high prevalence of menstrual pain presents a large patient pool requiring treatment and driving the demand for menstrual cramps treatment products.

Segment Analysis
Pain Relievers hold the dominant share in the menstrual cramps treatment market as they are the first line of treatment prescribed by doctors. Given their high efficacy and easy availability over the counter, pain relievers such as ibuprofen, naproxen and acetaminophen are able to provide quick relief from mild to moderate menstrual cramps. Heating pads is another major sub-segment which is gaining popularity due to providing non-pharmacological relief through its temporary pain reducing effect.

Key Takeaways

The global Menstrual Cramps Treatment market is expected to witness high growth.

Regional analysis: The Asia Pacific region is emerging as a lucrative market for menstrual cramps treatment. Rapidly improving healthcare infrastructure and growing women health concerns across developing economies such as India and China are creating high demand. Additionally, increasing endorsement ofperiod tracking apps byMillennialsand Generation Z are helping to normalize discussions around menstrual issues inthe region.

Key players operating in the Menstrual Cramps Treatment market are Stryker Corporation, SATELEC (Actongroup), Surgiform Innovative Surgical Products, Allergan (Abbvie) Luminera, Implantech, Koken, ANTHONY PRODUCTS INC., NOUVAG, Sihuan Pharmaceutical Holdings Group Ltd. Allergan (Abbvie) holds a substantialshare owing to its extensive pain management product portfolio including therapeutics, medical devices and nutritional supplements. Meanwhile, Stryker and ANTHONY PRODUCTS are prominent players in the surgical supplies segment.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more